Retrospective cohort study for assessment of association between imaging changes and outcome after treatment of regorafenib(KSCC1603)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 25 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Jan 2017 Status changed from not yet recruiting to recruiting.
- 27 Jul 2016 New trial record